CannLabs (CANL) Stock Chart & Stock Price History → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free CANL Stock Alerts $0.0011 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines CannLabs Stock Price Performance5 Day PerformanceN/A1 Month PerformanceN/A3 Month PerformanceN/A6 Month Performance-83.08%Year-To-Date Performance0.00%1 Year Performance-87.64% Receive CANL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CannLabs and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. CANL Stock Chart for Thursday, April, 25, 2024 CANL Chart by TradingView CannLabs Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/14/2024$0.00$0.00$0.00$0.004,000 shs$1.04 million03/13/2024$0.00$0.00$0.00$0.0018,996 shs$1.04 million02/29/2024$0.00$0.00$0.00$0.004,000 shs$1.04 million02/28/2024$0.00$0.00$0.00$0.004,000 shs$1.04 million02/27/2024$0.00$0.00$0.00$0.00200 shs$1.04 million02/26/2024$0.00$0.00$0.00$0.00200 shs$1.04 million01/29/2024$0.00$0.00-90.91%$0.00$0.002,000 shs$94,000.00 Related Companies: Vyant Bio Stock Price Chart Zicix Stock Price Chart Invitae Stock Price Chart Aclarion Stock Price Chart 9 Meters Biopharma Stock Price Chart Virax Biolabs Group Stock Price Chart Endonovo Therapeutics Stock Price Chart QHSLab Stock Price Chart Remedent Stock Price Chart Biodexa Pharmaceuticals Stock Price Chart Receive CANL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CannLabs and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:CANL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
